BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.2130
-0.0070 (-3.18%)
At close: Aug 18, 2026, 4:00 PM EDT
0.2298
+0.0168 (7.89%)
After-hours: Aug 18, 2026, 6:02 PM EDT
BioRestorative Therapies Market Cap
BioRestorative Therapies has a market cap or net worth of $5.43 million as of August 18, 2026. Its market cap has decreased by -55.15% in one year.
Market Cap
5.43M
Enterprise Value
1.86M
1-Year Change
-55.15%
Ranking
Category
Stock Price
$0.21
ChartMarket Cap Chart
Since November 5, 2021, BioRestorative Therapies's market cap has decreased from $6.50M to $5.43M, a decrease of -16.51%. That is a compound annual growth rate of -3.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 5.43M | -47.82% |
| Dec 31, 2025 | 10.40M | 5.05% |
| Dec 31, 2024 | 9.90M | 20.73% |
| Dec 29, 2023 | 8.20M | -18.81% |
| Dec 30, 2022 | 10.10M | -33.55% |
| Dec 31, 2021 | 15.20M | 133.85% |
| Nov 5, 2021 | 6.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 6.16M |
| CollPlant Biotechnologies | 6.04M |
| Curanex Pharmaceuticals | 6.03M |
| Addex Therapeutics | 6.01M |
| Cardio Diagnostics Holdings | 5.89M |
| Dermata Therapeutics | 5.87M |
| Processa Pharmaceuticals | 5.86M |
| PharmaCyte Biotech | 5.82M |